Advances in treatment of neurodegenerative diseases: Perspectives for combination of stem cells with neurotrophic factors

被引:35
|
作者
Wang, Jie [1 ,2 ]
Hu, Wei-Wei [3 ]
Jiang, Zhi [1 ]
Feng, Mei-Jiang [1 ,4 ]
机构
[1] Nanjing Med Univ, Dept Geriatr, Affiliated Hosp 2, Jiangjiayuan Rd 121, Nanjing 210011, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Dept Neurol, Affiliated Jiangning Hosp, Nanjing 211100, Jiangsu, Peoples R China
[3] Nanjing Univ, Jinling Hosp, Dept Geriatr, Sch Med, Nanjing 210002, Jiangsu, Peoples R China
[4] Nanjing Med Univ, Key Lab Aging & Dis, Jiangjiayuan Rd 121, Nanjing 210011, Jiangsu, Peoples R China
来源
WORLD JOURNAL OF STEM CELLS | 2020年 / 12卷 / 05期
关键词
Neurodegenerative diseases; Stem cells; Brain-derived neurotrophic factor; Glial cell line-derived neurotrophic factor; Nerve growth factor; Combination therapy; AMYOTROPHIC-LATERAL-SCLEROSIS; NERVE GROWTH-FACTOR; RAT MODEL; ALZHEIMERS-DISEASE; HUNTINGTONS-DISEASE; PARKINSONS-DISEASE; STROMAL CELLS; CEREBROSPINAL-FLUID; COGNITIVE DECLINE; PROGENITOR CELLS;
D O I
10.4252/wjsc.v12.i5.323
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis, are a group of incurable neurological disorders, characterized by the chronic progressive loss of different neuronal subtypes. However, despite its increasing prevalence among the ever-increasing aging population, little progress has been made in the coincident immense efforts towards development of therapeutic agents. Research interest has recently turned towards stem cells including stem cells-derived exosomes, neurotrophic factors, and their combination as potential therapeutic agents in neurodegenerative diseases. In this review, we summarize the progress in therapeutic strategies based on stem cells combined with neurotrophic factors and mesenchymal stem cells-derived exosomes for neurodegenerative diseases, with an emphasis on the combination therapy.
引用
收藏
页码:323 / 338
页数:16
相关论文
共 50 条
  • [31] Advances in the Treatment of Ischemic Diseases by Mesenchymal Stem Cells
    Li, Shujing
    Wang, Xianyun
    Li, Jing
    Zhang, Jun
    Zhang, Fan
    Hu, Jie
    Qi, Yixin
    Yan, Baoyong
    Li, Quanhai
    [J]. STEM CELLS INTERNATIONAL, 2016, 2016
  • [32] Adult Stem cells and neurodegenerative diseases
    Mazzini, Letizia
    Vercelli, Alessandro
    Ferrero, Ivana
    Mareschi, Katia
    Nasuelli, Nicola
    Monaco, Francesco
    Fagioli, Franca
    [J]. TISSUE ENGINEERING PART A, 2011, 17 (3-4) : 543 - 543
  • [33] Advances in the treatment of visual hallucinations in neurodegenerative diseases
    Collerton, Daniel
    Taylor, John-Paul
    [J]. FUTURE NEUROLOGY, 2013, 8 (04) : 433 - 444
  • [34] FUNCTION OF NEUROTROPHIC FACTORS IN THE ADULT AND AGING BRAIN AND THEIR POSSIBLE USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES - REPLY
    HEFTI, F
    HARTIKKA, J
    KNUSEL, B
    [J]. NEUROBIOLOGY OF AGING, 1989, 10 (05) : 552 - 553
  • [35] Adult stem cells -: perspectives in treatment of metabolic diseases
    Schulze, M
    Fändrich, F
    Ungefroren, H
    Kremer, B
    [J]. ACTA GASTRO-ENTEROLOGICA BELGICA, 2005, 68 (04) : 461 - 465
  • [36] Functional role of mesenchymal stem cells in the treatment of chronic neurodegenerative diseases
    Lo Furno, Debora
    Mannino, Giuliana
    Giuffrida, Rosario
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (05) : 3982 - 3999
  • [37] Autophagy deregulation in neurodegenerative diseases - recent advances and future perspectives
    Cheung, Zelda H.
    Ip, Nancy Y.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2011, 118 (03) : 317 - 325
  • [38] Special Issue: "Neurodegenerative Diseases: Recent Advances and Future Perspectives"
    Lopez-Cuenca, Ines
    De Hoz, Rosa
    [J]. BIOMEDICINES, 2024, 12 (05)
  • [39] Neurotrophic factors in the treatment of neurologic diseases
    Ochs, G
    Schrank, B
    Toyka, K
    Sendtner, M
    [J]. AKTUELLE NEUROLOGIE, 1997, 24 (04) : 170 - 174
  • [40] Growth factors in the treatment of neurodegenerative diseases
    Saarma, M.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S183 - S184